Health
COVID-19 vaccine tested at Emory is safe, generates immune response, early results show – Mirage News
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in production of…
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in production of both binding and neutralizing antibodies in healthy adult volunteers, according to interim results of an ongoing phase 1 trial published today in the New England Journal of Medicine.
The experimental vaccine is being co-developed by researchers at NIAID and at Moderna, Inc. of Cambridge, Massachusetts. Manufactured by Moderna, mRNA-1273 is designe…
Continue Reading